Phase i feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma

Clinical and Translational Oncology

Volumn 12, Issue 3, 2010, Pages 218-225

  Cárdenes, Higinia R ^a   Price, Tracy R ^a   Perkins, Susan M ^a   Maluccio, Mary ^a   Kwo, P ^a   Breen, T E ^a   Henderson, Mark A ^a   Schefter, Tracey E ^b   Tudor, Kathy ^a   Deluca, Jill ^a   Johnstone, Peter A S ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Hepatocellular carcinoma; Stereotactic body radiotherapy

Indexed keywords

ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN;

ADULT; AGED; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER CONTROL; CANCER MORTALITY; CAUSE OF DEATH; CHILD TURCOTTE PUGH CLASS; CLASSIFICATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; FEASIBILITY STUDY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; HYPERBILIRUBINEMIA; HYPOKALEMIA; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER TOXICITY; LIVER TRANSPLANTATION; MALE; OVERALL SURVIVAL; PRIMARY TUMOR; RADIATION DOSE FRACTIONATION; SEPSIS; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL TIME; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEASIBILITY STUDIES; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; RADIOSURGERY;

EID: 77952233924     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-010-0492-x     Document Type: Article

References (44)

1. D.M. Parkin F. Bray J. Ferlay, et al. 2005 Global cancer statistics, 2002 CA Cancer J Clinic 55 74 108 10.3322/canjclin.55.2.74
2. H.B. El-Serag A.C. Mason 1999 Rising incidence of hepatocellular carcinoma in the United States [see comment] N Engl J Med 340 745 750 10.1056/NEJM199903113401001 1:STN:280:DyaK1M7ls1ensg%3D%3D 10072408 (Pubitemid 29114292)
3. American Cancer Society (2009) Cancer facts and figures. American Cancer Society
4. V. Mazzaferro E. Regalia R. Doci, et al. 1996 Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 693 699 10.1056/NEJM199603143341104 1:STN:280: DyaK287nsFWltw%3D%3D 8594428 (Pubitemid 26079803)
5. J.M. Llovet J. Fuster J. Bruix 1999 Intention-to-treat analysis of surgical treatment for early heaptocellular carcinoma: resection versus transplantation [see comment] Hepatology 30 1434 1440 10.1002/hep.510300629 1:STN:280:DC%2BD3c%2Fkt1eiug%3D%3D 10573522
6. R. Vilana J. Bruix C. Bru, et al. 1992 Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma Hepatology 16 353 357 10.1002/hep.1840160212 1:STN:280: DyaK38zkslyjsw%3D%3D 1322349
7. L. Lui 2002 Radiofrequency ablation of liver cancers World J Gastroenterol 8 392 399
8. J.M. Llovet J. Bruix 2003 Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology 37 429 442 10.1053/jhep.2003.50047 1:CAS:528:DC%2BD3sXhsFeltrg%3D 12540794 (Pubitemid 36152543)
9. R. Salem R.D. Hunter 2006 Yttrium-90 microspheres for the treatment of hepatocellular carcinoma: a review Int J Radiat Oncol Biol Phys 66 S83 88 1:CAS:528:DC%2BD28Xps1Wlsb8%3D 16979447
10. J.M. Llovet S. Ricci V. Mazzaferro, et al. 2008 Sorafenib in advanced hepatocellular carcinoma [see comment] N Engl J Med 359 378 390 10.1056/NEJMoa0708857 1:CAS:528:DC%2BD1cXovFWjsL8%3D 18650514
11. R.A. Abrams T.F. Pajak T.L. Haulk, et al. 1998 Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center Cancer J Sci Am 4 178 184 1:STN:280:DyaK1c3nsFGntQ%3D%3D 9612600
12. G.B. Stillwagon S.E. Order C. Guse, et al. 1989 194 hepatocellular cancers treated by radiation and chemotherapy combinations: toxicity and response: a Radiation Therapy Oncology Group Study Int J Radiat Oncol Biol Phys 17 1223 1229 1:STN:280:DyaK3c%2Fptl2jtw%3D%3D 2557307
13. L.A. Dawson C.J. McGinn D. Normolle, et al. 2000 Escalated focal liver radiation and concurrent hepatic artery fl uorodeoxyuridine for unresectable intrahepatic malignancies J Clin Oncol 18 2210 2218 1:CAS:528: DC%2BD3cXktlagsb4%3D 10829040
14. M.-T. Liu S.-H. Li T.-C. Chu, et al. 2004 Threedimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization Jpn J Clin Oncol 34 532 539 10.1093/jjco/hyh089 15466827 (Pubitemid 43118049)
15. F. Mornex N. Girard C. Beziat, et al. 2006 Feasibility and efficacy of high-dose three-dimensionalconformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies: mature results of the French Phase II RTF-1 trial Int J Radiat Oncol Biol Phys 66 1152 1158 17145534
16. H.C. Park J. Seong K.H. Han, et al. 2002 Doseresponse relationship in local radiotherapy for hepatocellular carcinoma Int J Radiat Oncol Biol Phys 54 150 155 10.1016/S0360-3016(02)03283-2 12182985
17. I. Lax H. Blomgren I. Naslund, et al. 1994 Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects Acta Oncol 33 677 683 10.3109/02841869409121782 1:STN:280:DyaK2M%2Fjtlegug%3D%3D 7946448
18. H. Blomgren I. Lax H. Goranson 1998 Radiosurgery for tumors in the body: Clinical experience using a new method J Radiosurg 1 63 74 10.1023/B:JORA. 0000010880.40483.c4
19. H. Blomgren I. Lax I. Naslund, et al. 1995 Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients Acta Oncol 34 861 870 10.3109/02841869509127197 1:STN:280:DyaK28%2FjvVOqtQ%3D%3D 7576756
20. C.R. Kelsey T. Schefter S.R. Nash 2003 Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma: implications for extracranial stereotactic radiosurgery Int J Radiat Oncol Biol Phys 57 S283
21. L.A. Dawson C. Eccles J.-P. Bissonnette, et al. 2005 Accuracy of daily image guidance for hypofractionated liver radiotherapy with active breathing control Int J Radiat Oncol Biol Phys 62 1247 1252 15990028
22. Cancer Therapy Evaluation Program Website: ctep.cancer.gov/forms/CTCAEv3. pdf
23. R.N. Pugh I.M. Murray-Lyon J.L. Dawson, et al. 1973 Transection of the oesophagus for bleeding oesophageal varices Br J Surg 60 646 649 10.1002/bjs.1800600817 1:STN:280:DyaE3s3jsVWqsw%3D%3D 4541913
24. J. Bruix M. Sherman Practice Guidelines Committee AAftSoLD 2005 Management of hepatocellular carcinoma [see comment] Hepatology 42 1208 1236 10.1002/hep.20933 16250051 (Pubitemid 43112690)
25. M.A. Henderson F. Azzouz T. Breen 2007 Preliminary toxicity analysis of phase I/II trial evaluating stereotactic body radiotherapy for the treatment of hepatocellular carcinoma Int J Radiat Oncol Biol Phys 69 S297
26. D. Jones 1994 ICRU Report 50: prescribing, recording and reporting photon beam therapy Med Phys 21 833 834 10.1118/1.597396
27. ICRU (1999) Report 62: prescribing, recording and reporting photon beam therapy (supplement to ICRU Report 50). International Commission on Radiation Units and Measurements, Bethesda
28. P. Therasse S.G. Arbuck E.A. Eisenhauer, et al. 2000 New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada [see comment] J Natl Cancer Inst 92 205 216 10.1093/jnci/92.3.205 1:STN:280:DC%2BD3c7it1Gitg%3D%3D 10655437
29. E.L. Kaplan P. Meier 1958 Nonparametric estimation from incomplete observations J Am Stat Assoc 53 457 10.2307/2281868
30. R. Timmerman L. Papiez R. McGarry, et al. 2003 Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I nonsmall cell lung cancer Chest 124 1946 1955 10.1378/chest.124.5.1946 14605072 (Pubitemid 37433596)
31. R. Timmerman R. McGarry L. Papiez 2005 Initial report of a prospective phase II trial of stereotactic body radiation therapy for patients with medically inoperable stage I non-small cell lung cancer Int J Radiat Oncol Biol Phys 63 S99
32. L.A. Dawson D. Normolle J.M. Balter, et al. 2002 Analysis of radiation-induced liver disease using the Lyman NTCP model [see comment] [erratum appears in Int J Radiat Oncol Biol Phys 2002;53:1422] Int J Radiat Oncol Biol Phys 53 810 821 12095546
33. T.S. Lawrence R.K. Ten Haken M.L. Kessler, et al. 1992 The use of 3-D dose volume analysis to predict radiation hepatitis Int J Radiat Oncol Biol Phys 23 781 788 1:STN:280:DyaK38zhs1yjtg%3D%3D 1618671
34. J.T. Lyman 1985 Complication probability as assessed from dose-volume histograms Radiat Res 8 S13 19 10.2307/3576626 1:STN:280:DyaL287itFKjtg%3D%3D
35. J.-H. Cheng J.K. Wu C.M. Huang, et al. 2002 Radiation-induced liver disease after radiotherapy for hepatocellular carcinoma: clinical manifestation and dosimetric description Radiother Oncol 63 41 45 10.1016/S0167-8140(02)00061- 0 12065102 (Pubitemid 34626753)
36. J.-H. Cheng J.K. Wu P.C. Lee 2004 Biological susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiationinduced liver disease Int J Radiat Oncol Biol Phys 60 1502 1509 10.1016/j.ijrobp.2004. 06.069 15590181
37. Z.-Y. Xu S.-X. Liang J. Zhu, et al. 2006 Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma [see comment] Int J Radiat Oncol Biol Phys 65 189 195 16542787
38. K.K. Herfarth J. Debus F. Lohr, et al. 2001 Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial J Clin Oncol 19 164 170 1:STN:280:DC%2BD38%2Fgs1Sgsg%3D%3D 11134209
39. J. Wulf M. Guckenberger U. Haedinger, et al. 2006 Stereotactic radiotherapy of primary liver cancer and hepatic metastases Acta Oncol 45 838 847 10.1080/02841860600904821 16982548 (Pubitemid 44423130)
40. B.O. Choi H.S. Jang K.M. Kang, et al. 2006 Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma Jpn J Clin Oncol 36 154 158 10.1093/jjco/hyi236 16520355
41. A. Mendez Romero W. Wunderink S.M. Hussain, et al. 2006 Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase I/II study Acta Oncol 45 831 837 10.1080/02841860600897934 16982547 (Pubitemid 44423129)
42. R.V. Tse M. Hawkins G. Lockwood, et al. 2008 Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma J Clin Oncol 26 657 664 10.1200/JCO.2007.14.3529 18172187 (Pubitemid 351264363)
43. B.G. Douglas J.F. Fowler 1976 The effect of multiple small doses of x rays on skin reactions in the mouse and a basic interpretation Radiat Res 66 401 426 10.2307/3574407 1:STN:280:DyaE287nslWntg%3D%3D 1265229
44. C. Park L. Papiez S. Zhang, et al. 2008 Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy Int J Radiat Oncol Biol Phys 70 847 852 18262098